Gene · 84717
Papers2,323
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,323
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Estimating malaria antigen dynamics and the time to negativity of next-generation malaria rapid diagnostic tests. | Malar J | 2025 | 40186233 | PubTator, text mining | PubMed |
| Exome-wide association study reveals 7 functional variants associated with ex-vivo drug response in acute myeloid leukemia patients. | BMC Med Genomics | 2025 | 40186177 | PubTator, text mining | PubMed |
| HRP2 regulating MICU1-mediated Ca2+ overload to dictate chemoresistance of multiple myeloma. | Neoplasia | 2025 | 40058268 | PubTator, text mining | PubMed |
| Exploring Biomarkers for Malaria: Advances in Early Detection and Asymptomatic Diagnosis. | Biosensors (Basel) | 2025 | 39997008 | PubTator, text mining | PubMed |
| Evaluation of CareStart™ malaria HRP2/pLDH (Pf/PAN) combo rapid diagnostic test for diagnosis of Plasmodium falciparum infection in malaria co-endemic areas in association with parasite density. | Malar J | 2025 | 39930468 | PubTator, text mining | PubMed |
| Assessment of Malaria Rapid Diagnostic Tests and Histidine-Rich Protein 2 Deletions among Asymptomatic Children and Adults in Bagamoyo, Tanzania. | Am J Trop Med Hyg | 2025 | 39836975 | PubTator, text mining | PubMed |
| TDP-43 Cryptic RNAs in Perry Syndrome: Differences across Brain Regions and TDP-43 Proteinopathies. | Mov Disord | 2025 | 39788898 | PubTator, text mining | PubMed |
| Loss of TDP-43 Splicing Repression Occurs in Myonuclei of Inclusion Body Myositis Patients. | Ann Neurol | 2025 | 39757935 | PubTator, text mining | PubMed |
| Very low prevalence of Plasmodium falciparum histidine-rich protein 2 (pfhrp2) gene deletion in the Brazil, Venezuela, and Guyana tri-border. | Sci Rep | 2025 | 39753650 | PubTator, text mining | PubMed |
| Bola-Amphiphilic Dendrimer Enhances Imatinib to Target Metastatic Ovarian Cancer via β-Catenin-HRP2 Signaling Axis. | ACS Appl Mater Interfaces | 2025 | 39752231 | PubTator, text mining | PubMed |
| Post-treatment duration of positivity for standard and ultra-sensitive Plasmodium falciparum antigen-based rapid diagnostic tests, a cohort study from a low-endemic setting in Namibia. | EBioMedicine | 2025 | 39657364 | PubTator, text mining | PubMed |
| The spread of molecular markers of artemisinin partial resistance and diagnostic evasion in Eritrea: a retrospective molecular epidemiology study. | Lancet Microbe | 2025 | 39653047 | PubTator, text mining | PubMed |
| Prevalence of Asymptomatic non-Falciparum and Falciparum Malaria in the 2014-15 Rwanda Demographic Health Survey. | medRxiv | 2025 | 38260604 | PubTator, text mining | PubMed |
| Molecular surveillance of Plasmodium falciparum histidine-rich protein 2/3 gene deletions in Mozambique, 2023. | Malar J | 2024 | 39725959 | PubTator, text mining | PubMed |
| Low prevalence of Plasmodium falciparum histidine-rich protein 2 and 3 gene deletions in malaria-endemic states of India. | PLoS One | 2024 | 39693284 | PubTator, text mining | PubMed |
| Evaluation of three rapigen biocredit point-of-care tests for malaria case management in Lagos, Nigeria. | J Infect Dev Ctries | 2024 | 39693172 | PubTator, text mining | PubMed |
| Motion Planning and Control with Environmental Uncertainties for Humanoid Robot. | Sensors (Basel) | 2024 | 39686186 | PubTator, text mining | PubMed |
| Subclinical malaria among pregnant women living in refugee settlements in Northern Uganda. | Ther Adv Infect Dis | 2024 | 39513092 | PubTator, text mining | PubMed |
| Rational fragment-based design of compounds targeting the PWWP domain of the HRP family. | Eur J Med Chem | 2024 | 39461037 | PubTator, text mining | PubMed |
| HDGFL2 cryptic protein: a portal to detection and diagnosis in neurodegenerative disease. | Mol Neurodegener | 2024 | 39456026 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84717/papers?page=5